Photo of Susan M. Collins
R United States Senate · Maine On the 2026 ballot

Sen. Susan M. Collins

Compare
Total votes
1,044
all sessions
Attendance
100%
of floor votes
Higher than 92% of chamber peers
With party
72%
of cast votes
Among the lowest in the chamber
Bipartisan score
15%
some cross-party votes
Higher than 99% of chamber peers
Sponsored
1,436
bills & resolutions
Near the chamber average
Committees
16
assignments
1,436 bills and resolutions

Sponsored bills

Total
1,436
Primary
117
Co-sponsor
1,319
This page
1,436
matching current filters
Co-sponsor SRES 379
Passed · Indiana Senate · Co-sponsor
A resolution expressing support for the designation of the week of September 13, 2021, through September 17, 2021, as "National Small Business Week" to celebrate the contributions of small businesses and entrepreneurs in every community in the United States.

This resolution honors the contributions of small businesses in the United States and supports the designation of National Small Business Week.

Passed Sep 22, 2021 1 co-sponsor
Primary S 2808
In committee · Indiana Senate · Lead sponsor
Justice for the Living Victims of Lockerbie Act

Justice for the Living Victims of Lockerbie Act This bill establishes a mechanism for compensating certain victims of the bombing of Pan American Flight 103 over Lockerbie, Scotland, on December 21, 1988. Specifically, the Department of the Treasury must establish a fund to compensate qualifying victims of the bombing (generally, former employees of Pan American who were part of an earlier lawsuit seeking compensation from Libya for the bombing). The Foreign Claims Settlement Commission must establish a process for claimants to apply for compensation from the fund.

In committee Sep 22, 2021 0 co-sponsors
Co-sponsor S 2790
In committee · Indiana Senate · Co-sponsor
Consumer Financial Protection Bureau Accountability Act of 2021

Consumer Financial Protection Bureau Accountability Act of 2021 This bill changes the source of funding for the Consumer Financial Protection Bureau (CFPB) from Federal Reserve System transfers to annual appropriations. Under current law, the transfers from the Federal Reserve System permit the CFPB to be funded outside of the annual appropriations process.

In committee Sep 21, 2021 1 co-sponsor
Co-sponsor S 2753
In committee · Indiana Senate · Co-sponsor
Protecting Children of Long-term Visa Holders Act of 2021

America's Children Act or the Protecting Children of Long-term Visa Holders Act of 2021 This bill provides lawful permanent resident status to certain college graduates who entered the United States as children and addresses other immigration-related issues. Specifically, this bill allows an alien to apply for lawful permanent resident status if the alien (1) was lawfully admitted into the United States as a dependent child of an alien on a temporary worker visa, (2) was in the United States with such status for at least four years, (3) has graduated from an institution of higher education in the United States, and (4) is not deportable or otherwise inadmissible. In addition, the alien must have been lawfully present in the United States for at least 10 years at the time of the application. The bill also modifies various provisions related to the calculation of an alien's age for immigration purposes and the priority date of certain immigration-related applications.

In committee Sep 15, 2021 1 co-sponsor
Co-sponsor S 2732
In committee · Indiana Senate · Co-sponsor
John Stringer Rainey SAFE Act

John Stringer Rainey Save America's Forgotten Equines Act or the John Stringer Rainey SAFE Act This bill prohibits the knowing sale or transport of horses for purposes of human consumption. Specifically, the bill makes it unlawful to knowingly possess, ship, transport, purchase, sell, deliver, or receive a horse for it to be slaughtered for human consumption. It also makes it unlawful to knowingly possess, ship, transport, purchase, sell, deliver, or receive horse flesh, carcass, or part of a carcass for it to be used for human consumption. Violators are subject to criminal penalties.

In committee Sep 14, 2021 1 co-sponsor
Co-sponsor S 808
In committee · Indiana Senate · Co-sponsor
Cybersecurity Disclosure Act of 2021

Cybersecurity Disclosure Act of 2021 This bill directs the Securities and Exchange Commission to issue final rules requiring a registered issuer of securities to disclose in its mandatory annual report or annual proxy statement whether any member of its governing body has expertise or experience in cybersecurity. If no member has such expertise or experience, the issuer must describe what other company cybersecurity aspects were taken into account by the persons responsible for identifying and evaluating nominees for the governing body.

In committee Sep 14, 2021 1 co-sponsor
Co-sponsor S 2718
In committee · Indiana Senate · Co-sponsor
Due Process Guarantee Act

Due Process Guarantee Act This bill limits the detention authority of the United States. Current law prohibits the indefinite detention of a U.S. citizen unless it is authorized by an act of Congress. This bill prohibits the indefinite detention of a U.S. citizen or lawful permanent resident unless it is authorized by an act of Congress that (1) is consistent with the Constitution, and (2) expressly authorizes the detention. Additionally, the bill specifies that no U.S. citizen or lawful permanent resident who is apprehended in the United States may be imprisoned or otherwise detained without charge or trial unless such imprisonment or detention is expressly authorized by an act of Congress. Finally, it specifies that a general authorization to use military force or similar measure, on its own, does not authorize the indefinite detention of a person who is arrested in the United States.

In committee Sep 13, 2021 1 co-sponsor
Co-sponsor S 2706
In committee · Indiana Senate · Co-sponsor
DIVERSE Trials Act

Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act or the DIVERSE Trials Act This bill requires activities to increase diversity in clinical trials. It also expands reporting by laboratories that test for and diagnose COVID-19 and requires a study on data collection and data sharing during public health emergencies. Specifically, the Food and Drug Administration (FDA) must issue guidance on decentralized clinical trials to promote meaningful demographic and geographic diversity in patient engagement, enrollment, and participation. Decentralized clinical trials include those executed through telemedicine or other digital technologies to allow for the remote collection and assessment of clinical trial data. The FDA may also work with foreign regulators to harmonize international regulations governing decentralized clinical trials and the use of digital health technology. In addition, the Department of Health and Human Services (HHS) may support community education, outreach, and recruitment activities for clinical trials of treatments for conditions that disproportionately impact populations underrepresented in clinical trials. The bill also specifies that drug or device manufacturers may provide, subject to some limits, free digital health technologies and other remuneration to patients in approved clinical trials without violating laws that address fraud and abuse in federal programs. Furthermore, laboratories that test for and diagnose COVID-19 must report additional demographic data, including information about social determinants of health. HHS must also contract with the National Academy of Medicine to study and propose a design for an interoperable platform to facilitate data sharing during public health emergencies.

In committee Aug 10, 2021 1 co-sponsor
Showing 1,161 to 1,170 of 1,436 bills